KalVista Pharmaceuticals, Inc. 8-K SEC Filings

Filed On	Filing
11 Jun 2026	8-K: Entry into a Material Definitive Agreement; Termination of a Material Definitive Agreement +8 more
29 Apr 2026	8-K: Entry into a Material Definitive Agreement; Regulation FD Disclosure
25 Mar 2026	8-K: Results of Operations and Financial Condition
08 Jan 2026	8-K: Results of Operations and Financial Condition; Regulation FD Disclosure
10 Nov 2025	8-K: Results of Operations and Financial Condition
06 Oct 2025	8-K: Departure/Election of Directors or Officers; Compensation; Regulation FD Disclosure
02 Oct 2025	8-K: Departure/Election of Directors or Officers; Compensation; Submission of Matters to a Vote of Security Holders +1 more
29 Sep 2025	8-K: Entry into a Material Definitive Agreement; Creation of a Direct Financial Obligation +2 more
11 Sep 2025	8-K: Results of Operations and Financial Condition
21 Aug 2025	8-K: Other Events
10 Jul 2025	8-K: Results of Operations and Financial Condition
07 Jul 2025	8-K: Regulation FD Disclosure; Other Events
12 May 2025	8-K: Departure/Election of Directors or Officers; Compensation
08 Apr 2025	8-K: Entry into a Material Definitive Agreement; Regulation FD Disclosure
17 Mar 2025	8-K: Amendments to Articles/Bylaws; Change in Fiscal Year
12 Mar 2025	8-K: Results of Operations and Financial Condition
16 Dec 2024	8-K: Departure/Election of Directors or Officers; Compensation; Regulation FD Disclosure
05 Dec 2024	8-K: Results of Operations and Financial Condition
26 Nov 2024	8-K: Departure/Election of Directors or Officers; Compensation; Regulation FD Disclosure
04 Nov 2024	8-K: Entry into a Material Definitive Agreement; Unregistered Sales of Equity Securities +1 more

Comments